Announcement of the General Administration of the people's Republic of China on canceling the registration approval documents of 22 products such as azithromycin and sodium chloride injection
-
Last Update: 2016-07-25
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the application of 7 enterprises such as Jichuan Pharmaceutical Group Co., Ltd., the State Food and Drug Administration decided to cancel the registration and approval documents of 22 products such as azithromycin sodium chloride injection (see the appendix for the catalog of varieties and cancellation situation) It is hereby announced Appendix: Catalogue of types of approval documents for deregistration Appendix Docx appendix to Announcement No 122 of food and Drug Administration on July 13, 2016 Serial no of catalogue of types of approval documents for deregistration Name of varieties Approval Certificate No specification dosage form production enterprise cancellation situation 1 azithromycin sodium chloride injection Gyzz h20030781 100ml: azithromycin 0.125g and sodium chloride 0.9g injection Jichuan Pharmaceutical Group Co., Ltd enterprise application 2 azithromycin and sodium chloride injection (GJZ h20030782 250ml): Azithromycin 0.25g and sodium chloride 2.25g Jichuan Pharmaceutical Group Co., Ltd enterprise application 3 lifuding capsule gyzz h32025586 0.15g Application of capsule Jichuan Pharmaceutical Group Co., Ltd for 4 Fuma nasal drops gjzz h32026087 10ml nasal drops Jichuan Pharmaceutical Group Co., Ltd enterprise applies for 5 sterilized water for injection Guoyao Zhunzi h20033904 0.6ml injection Jiangsu desino Pharmaceutical Co., Ltd enterprise application 6 Amoxicillin capsule gyzz h20023611 0.25g capsule Nanjing Changao Pharmaceutical Co., Ltd enterprise application 7 erythromycin eye ointment GJZ h37022720 0.5% eye ointment Shandong Health Pharmaceutical Co., Ltd enterprise application 8 pediatric compound thymol powder GJZ h37023604 compound powder Shandong Health Pharmaceutical Co., Ltd Application of enterprise 9: acarboxyl powder GJZ h37023169: paracetamol 0.126g, aspirin 0.23g, caffeine 30mg Enterprise application for 10 compound belladonna aluminum hydroxide powder GJZ h37023449 Enterprise application for 11 compound zinc oxide salicylic acid powder Gyzz h37023517 compound powder Shandong Health Pharmaceutical Co., Ltd enterprise application 12 Sulfathiazole ointment GJZ h37022326 10g: 0.1g ointment Shandong Health Pharmaceutical Co., Ltd enterprise application 13 anluotong tablet Guoyao Zhunzi z37021575 0.1g tablet Shandong Weifang Pharmaceutical Factory Co., Ltd enterprise application 14 anluotong capsule Guoyao Zhunzi z37021572 0.1g capsule Shandong Weifang Pharmaceutical Factory Co., Ltd Enterprise application for 15 dexamethasone sodium phosphate injection GJZ h37021058 1ml: 2mg injection Shandong Weifang Pharmaceutical Factory Co., Ltd applies for 16 dexamethasone sodium phosphate injection gyzz h37020964 1ml: 5mg Injection Shandong Weifang Pharmaceutical Factory Co., Ltd enterprise application 17 Ozagrel gjzz h20056652 - Application of 18 nitroglycerin patch by Shandong Weifang Pharmaceutical Factory Co., Ltd Guoyao Zhunzi h37023416 25mg patch Shandong Weifang Pharmaceutical Factory Co., Ltd enterprise application 19 Salbutamol aerosol Guoyao Zhunzi h37023628 14g / bottle, salbutamol 28mg / bottle, salbutamol 0.14mg/print, Weifang Zhongshi Pharmaceutical Co., Ltd Enterprises apply for 20 salbutamol aerosol, gjzz h37022160, 20.4g for each bottle, 24.0mg for salbutamol, 0.10mg for each press Weifang Zhongshi Pharmaceutical Co., Ltd applies for 21 mannitol gjzz h37020736 - API Qingdao Yulong seaweed Co., Ltd enterprise application 22 idyzz h37020735 - Enterprise Application of Qingdao Yulong seaweed Co., Ltd
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.